Table 2. Adherence results.

	Questionnaire score	p*	MPR	p*
IMID, mean (SD); median (min-max)		0.710		0.091
Lenalidomide	8.3 (1.0); 9 (6–10)		0.97 (0.06); 0.98 (0.76–1.09)
Pomalidomide	7.9 (1.6); 8 (4–10)		0.96 (0.04); 0.98 (0.91–1.00)
Thalidomide	8.2 (0.9); 8 (6–9)		1.01 (0.07); 1.00 (0.92–1.19)
Total	8.2 (1.2); 8 (4–10)		0.97 (0.06); 0.98 (0.76–1.19)

MPR, Medication Possession Ratio; SD, Standard Deviation.

*Kruskal-Wallis test